Wednesday June 19, 2013




Home »  News »  Agriculture

Bogus horse anemia treatment resurfaces

Counterfeit Hippiron 1000 suspected in horse's death in '06

Yet another counterfeit version of an Ontario pharma firm's equine anemia treatment has reportedly been found in circulation for sale online.

Belleville, Ont.-based Bioniche Life Sciences said unknown parties have produced counterfeits of the company's intravenous (IV) iron-sucrose product, Hippiron 1000. The genuine product is used to treat iron deficiency in horses.

The fake Hippiron "was discovered being sold via an Internet website," Bioniche said in a release Thursday.

Bioniche said it's alerted federal regulators and vets to the problem, and provided them with lists of the "elements of the counterfeited product" distinguishing it from the real thing.

Bioniche didn't list any specific differences between the bona fide and bogus products in Thursday's release. Hippiron 1000 is sold in Canada both in individual 50-millilitre vials and in packs of 25 vials.

The company didn't say in its release whether the fake product cited in Thursday's warning represents a new run of counterfeit wares -- or if it's part of the same counterfeit batch on which Health Canada issued a public warning in 2006.

The warnings from Health Canada and Bioniche that year followed the death of a horse in Ontario and serious reactions in two other horses. All three of those cases followed "the administration of a counterfeit product sourced from a feed store," Bioniche said in 2006.

Hippiron 1000, Bioniche said, is currently the only licensed product of its kind available for veterinary use in Canada and is available only through vets and vet clinics.

"Any Hippiron 1000 that has not been purchased from a veterinarian or veterinary clinic should not be used," Health Canada said in 2006.

Bioniche said at the time, and repeated Thursday, that it "plans to prosecute any individual involved in the manufacturing, marketing, and/or labelling of counterfeited product."


Comments


NOTE: To post a comment in the new commenting system you must have an account with at least one of the following services: Disqus, Facebook, Twitter, Yahoo, OpenID. You may then login using your account credentials for that service. If you do not already have an account you may register a new profile with Disqus by first clicking the "Post as" button and then the link: "Don't have one? Register a new profile".

The Estevan Mercury welcomes your opinions and comments. We do not allow personal attacks, offensive language or unsubstantiated allegations. We reserve the right to edit comments for length, style, legality and taste and reproduce them in print, electronic or otherwise. For further information, please contact the editor or publisher, or see our Terms and Conditions.

blog comments powered by Disqus





Quick Vote

Survey results are meant for general information only, and are not based on recognised statistical methods.


Markets





LOG IN



Lost your password?